Investigational Sanofi drug shows improvements in MS patients
CAMBRIDGE, Mass. — More than three-quarters of patients with multiple sclerosis using a drug made by Sanofi subsidiary Genzyme did not experience disease relapse for two years, according to results of a late-stage clinical trial revealed over the weekend.
The drug maker announced Saturday results of the "CARE-MS I" trial, the first of two phase-3 clinical trials comparing the investigational drug Lemtrada (alemtuzumab) with Pfizer’s and EMD Serono’s Rebif (interferon beta-1a) in patients with relapsing-remitting MS.
Data from the trial showed that after two years, 78% of patients taking Lemtrada remained relapse-free, compared with 59% of those taking Rebif.
Walmart looks to bring holiday cheer with Christmas price guarantee
BENTONVILLE, Ark. — Walmart announced that it is helping ensure customers pay the lowest price on holiday gifts with the launch of its Christmas price guarantee.
Customers who purchase eligible product at Walmart anytime between Nov. 1 and Dec. 25, and then find those same products advertised for less at another store, will receive a Walmart gift card for the difference through Dec. 25.
"The greatest gift we can give our customers this holiday is great low prices on the things they want most," said Duncan Mac Naughton, chief merchandising officer for Walmart U.S. "Walmart is easing shopping stress this Christmas by allowing customers to shop when and how they want, all while guaranteeing low prices through the entire holiday season."
Walmart’s Christmas price guarantee is valid on purchases made Nov. 1 through Dec. 25 on identical items (the same brand, size, color, quantity, grade and model number) that currently are available at competitor’s stores located within the same local market as a particular Walmart store. To apply for the Christmas price guarantee, customers need to simply bring in their original Walmart cash register receipt and the local competitor’s current printed ad to Walmart’s customer service desk through Dec. 25. Once validated, a gift card for the difference will be issued. Items placed on layaway also will be eligible for the Christmas price guarantee.
FDA to healthcare professionals: Stop administering flu shots via jet injectors
WASHINGTON — The Food and Drug Administration on Friday issued guidance regarding the use of injector devices to administer flu vaccines to patients.
The FDA said that healthcare professionals should not use such clinical devices to administer flu vaccines, adding that all vaccines, including influenza, "be administered in accordance with their labeling."
"At this time, there are no vaccines for the prevention of influenza disease that are approved by the FDA for administration by jet injector … [they] have not been evaluated for delivery by jet injection," the FDA said in its guidance.
Only one vaccine is approved for administration via jet injector: the measles mumps and rubella vaccine (also known as MMR), the agency said, adding that it has no safety and efficacy data for other vaccines delivered by jet injector.
For more information, click here.